Surgical Device for Pelvic Organ Prolapse Treatment
Summary
The USPTO has published a patent application (US20260083543A1) for a surgical device designed for treating pelvic organ prolapse, specifically uterine prolapse. The application was filed on November 2, 2022, and published on March 26, 2026.
What changed
The United States Patent and Trademark Office (USPTO) has published a new patent application, US20260083543A1, detailing a surgical device and associated methods for treating pelvic organ prolapse, with a specific focus on uterine prolapse. The application was filed by inventor Salwan Hamoudi Musa AL-SALIHI and published on March 26, 2026, with a filing date of November 2, 2022.
This publication represents a new patent application and does not impose immediate regulatory obligations on entities. However, it signals innovation in the medical device sector related to women's health. Companies involved in the development, manufacturing, or marketing of surgical devices for gynecological conditions should be aware of this patent filing as it may impact future product development, intellectual property strategies, and market competition.
Source document (simplified)
A SURGICAL DEVICE
Application US20260083543A1 Kind: A1 Mar 26, 2026
Inventors
Salwan Hamoudi Musa AL-SALIHI
Abstract
The present disclosure relates to a devices and methods for use in surgery. In particular, the present disclosure is directed to devices and methods for the treatment of pelvic organ prolapse conditions, and in particular for the treatment of uterine prolapse.
CPC Classifications
A61F 2/0045 A61B 17/4241 A61B 2017/4225
Filing Date
2022-11-02
Application No.
19126579
Related changes
Source
Classification
Who this affects
Taxonomy
Browse Categories
Get Healthcare alerts
Weekly digest. AI-summarized, no noise.
Free. Unsubscribe anytime.
Get alerts for this source
We'll email you when ChangeBridge: Patent Apps - Prosthetics (A61F) publishes new changes.